Vakcīnas pret hepatītu B hemodialīzes pacientiem iegāde
Nacionālais veselības dienests
Published and bidding deadline .
Integrity Indicators
2 out of 3- No disputes from bidders or outsiders
- Sellers have not recently made any political party donations
- Bidding period is associated with an increased risk factor
Estimated Cost
Actual Cost
Duration
17 daysBidders
0 biddersBids
0 bidsDisputes
0 disputesVakcīnas pret hepatītu B hemodialīzes pacientiem iegāde
Process Type | Unknown |
---|---|
Offers Revealed At |
Contracts
GlaxoSmithKline Latvia SIAaward-1. Vakcīnas pret hepatītu B hemodialīzes pacientiem iegāde Signed . | €20,540 est. €20,540 |